Allogene Therapeutics, Inc.ALLONASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank63
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-181.36M
↑ 12% vs avg
Percentile
P63
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-206.01M
Historical baseline
PeriodValueYoY Change
TTM$-181.36M+25.5%
2024$-243.33M+22.3%
2023$-313.07M+2.5%
2022$-321.24M-89.3%
2021$-169.74M+28.9%
2020$-238.68M-32.7%
2019$-179.90M+13.0%
2018$-206.76M-939936.4%
2017$22000.00-